Building on shaky foundations? 'No way' says Sartorius
Award-winning building protected by special construction against vibration and temperature fluctuations.
Sartorius has officially opened it its approximately 42-million-euro building as part of Sartorius Campus for the manufacture of laboratory instruments. The new facility provides high-quality production conditions and an advanced, efficient work environment. Around 450 employees build laboratory instruments, such as balances, ultrapure water systems and moisture analysers at this facility covering about 25,000 m2 (270,000 sq. ft.) in the industrial zone of Grone in Goettingen.
The production facility, to which the State of Lower Saxony and the German federal government together contributed 4.2 million euro, represents the largest single investment of Sartorius Campus. On the whole, Sartorius is investing around 500 million euro in its Campus up to completion of construction scheduled for the end of 2018. The new Group headquarters will combine two Goettingen sites and, apart from providing more capacity for manufacture and administration, offers an attractive work environment. Moreover, the Campus grounds covering around 170,000 m2 (1,829,865 sq. ft.), can be used to further expand its facilities.
Speaking to CPHI-Online, Sartorius explained they made the significant investment so they could benefit from the increased capacity, both now and in the future. In addition, production times, which at the old site were very good, are now even better. The move to having everything under one roof has also positively affected production logistics.
The new building combines different manufacturing sites, formerly spread out at various locations, all under one roof: parts manufacture, prototype construction, calibration center, an extended vocational training workshop and an administration complex. Glass expanses of close to 7,000 m2 (75,350 sq. ft.), provide plenty of daylight throughout all areas of the building; a modern office design permits efficient work. As highly accurate balances are also calibrated inside, the building is protected from temperature fluctuations and protected by a foundation isolated from vibration by decoupling.
At the beginning of this year, the building won the 2017 Engineering Award of the German Structural Steel Industry, "Ingenieurpreis des Deutschen Stahlbaues" in the category of highrise building construction. The jury of the prize sponsor bauforumstahl e.V. lauded this construction as a symbol of the dynamics and solid quality workmanship of the laboratory balances manufactured at the facility. In addition, Sartorius is aiming to have this new building certified by the German Society for Sustainable Building, DGNB.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance